Showing 861-870 of 1746 results for "".
Considerations for Custom Lens Replacement
https://modernod.com/topics/presbyopia/considerations-for-custom-lens-replacement/38674/An advanced IOL may be the answer for certain patients seeking independence from glasses or contact lenses.Why Optometry Must Become Even More Involved in Cataract Comanagement
https://modernod.com/mod-issues/2019-mar/why-optometry-must-become-even-more-involved-in-cataract-comanagement/39051/Setting your patients and surgeon up for success.A Medical Practice Rooted in Contact Lenses
https://modernod.com/topics/contact-lenses/a-medical-practice-rooted-in-contact-lenses/37952/Why having a contact lens business necessitates a medical practice.Ocular Diseases That Are More Common in Women
https://modernod.com/mod-issues/2020-july-aug/ocular-diseases-that-are-more-common-in-women/38109/Screening can help identify systemic conditions that manifest in the eye.Lutemax 2020: Lutein for Every Age
https://modernod.com/mod-issues/supplements-inserts/lutemax-2020-lutein-for-every-age/38862/How supplementation of OmniActive’s lutein and zeaxanthin ingredients benefit patients of every age.New Vision Health Features Available on Apple Products
https://modernod.com/articles/significant-findings/new-vision-health-features-available-on-apple-products/37740/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatWhy the Medical Model Makes Good Financial Sense
https://modernod.com/topics/business/why-the-medical-model-makes-good-financial-sense/38485/A closer look at the practice of medical optometry and its benefits, including the ability to provide greater care to patients.TFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug B2. Myopia Control: Treatment Options and Upcoming Research
https://modernod.com/podcasts/four-eyes/2-myopia-control-treatment-options-and-upcoming-research/36952/We review treatment options related to myopia control including the new FDA approved lenses MiSight 1-Day by CooperVision, and share upcoming research in this area from Keyur Savla, BOptom and Celia Gong, OD.Resources:1. Review of Optometry Article on Myopia Treatments: https://www.reviewofoptometryA Place for House Calls in Optometry
https://modernod.com/topics/patient-care/a-place-for-house-calls-in-optometry/38789/Consider delivering eye care where it’s needed most.